Indications & formulation #
Selected alcohol-dependence treatment with informed participation. This reference covers the selected formulation; other indications and products need their own evidence.
Dose reference #
Adult educational reference · Oral tablet · United States. The clinician selects treatment after assessment; this page does not calculate or change a prescription.
After at least 12 hours abstinence, label initiation is up to 500 mg/day for 1–2 weeks; usual maintenance 250 mg/day, range 125–500 mg/day.
Contraindications & important cautions #
Never administer covertly or during intoxication. Avoid metronidazole, severe myocardial disease/coronary occlusion and psychosis.
Selected important cautions; consult the full product information for all contraindications and warnings.
Adverse effects #
Alcohol reaction, hepatotoxicity and neuropathy.
Interactions #
Review metronidazole, warfarin, phenytoin and hidden alcohol.
Monitoring #
Monitor liver symptoms/tests, understanding, consent and adherence.
Special populations #
Assess hepatic disease and interactions; baseline and follow-up liver tests are important. Pregnancy requires individual review.
Adult scope. Pregnancy, breastfeeding and pediatric use require the exact product’s population-specific guidance and individual assessment.
Discontinuation, restarting & counseling #
Alcohol reactions remain possible for up to 14 days after stopping. Explain hidden alcohol sources and urgent symptoms.
Brands & products #
Historical catalogue observations. Prices and catalogue presence do not establish current availability or Indian approval.
Reference coverage #
Structured summary of selected adult uses, not an exhaustive monograph. Indian product authorization and local prescribing requirements have not been reconciled.
References · 1
- Disulfiram — Oral tablet — selected prescribing information · United States · Checked 2026-10-27 · Selected formulation: Oral tablet · Supports indications, dose, cautions, adverse effects, interactions, monitoring, special populations and stopping. Source sections: Indications and usage; Dosage and administration; Contraindications; warnings and precautions; Use in specific populations; patient counseling
